stocks logo

PAVM Valuation

PAVmed Inc
$
0.571
-0.011(-1.891%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

PAVM Relative Valuation

PAVM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PAVM is overvalued; if below, it's undervalued.

Historical Valuation

PAVmed Inc (PAVM) is now in the Fair zone, suggesting that its current forward PS ratio of 42.54 is considered Fairly compared with the five-year average of -3.08. The fair price of PAVmed Inc (PAVM) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:0.57
Fair
-0.59
PE
1Y
3Y
5Y
Trailing
Forward
-2.45
EV/EBITDA
PAVmed Inc. (PAVM) has a current EV/EBITDA of -2.45. The 5-year average EV/EBITDA is -3.51. The thresholds are as follows: Strongly Undervalued below -10.45, Undervalued between -10.45 and -6.98, Fairly Valued between -0.05 and -6.98, Overvalued between -0.05 and 3.42, and Strongly Overvalued above 3.42. The current Forward EV/EBITDA of -2.45 falls within the Historic Trend Line -Fairly Valued range.
-1.79
EV/EBIT
PAVmed Inc. (PAVM) has a current EV/EBIT of -1.79. The 5-year average EV/EBIT is -3.42. The thresholds are as follows: Strongly Undervalued below -11.72, Undervalued between -11.72 and -7.57, Fairly Valued between 0.74 and -7.57, Overvalued between 0.74 and 4.89, and Strongly Overvalued above 4.89. The current Forward EV/EBIT of -1.79 falls within the Historic Trend Line -Fairly Valued range.
42.27
PS
PAVmed Inc. (PAVM) has a current PS of 42.27. The 5-year average PS is 65.80. The thresholds are as follows: Strongly Undervalued below -141.30, Undervalued between -141.30 and -37.75, Fairly Valued between 169.35 and -37.75, Overvalued between 169.35 and 272.90, and Strongly Overvalued above 272.90. The current Forward PS of 42.27 falls within the Historic Trend Line -Fairly Valued range.
-0.71
P/OCF
PAVmed Inc. (PAVM) has a current P/OCF of -0.71. The 5-year average P/OCF is -5.90. The thresholds are as follows: Strongly Undervalued below -32.79, Undervalued between -32.79 and -19.35, Fairly Valued between 7.54 and -19.35, Overvalued between 7.54 and 20.99, and Strongly Overvalued above 20.99. The current Forward P/OCF of -0.71 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
PAVmed Inc. (PAVM) has a current P/FCF of 0.00. The 5-year average P/FCF is -2.74. The thresholds are as follows: Strongly Undervalued below -12.67, Undervalued between -12.67 and -7.70, Fairly Valued between 2.23 and -7.70, Overvalued between 2.23 and 7.20, and Strongly Overvalued above 7.20. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
PAVmed Inc (PAVM) has a current Price-to-Book (P/B) ratio of 0.53. Compared to its 3-year average P/B ratio of 0.62 , the current P/B ratio is approximately -13.85% higher. Relative to its 5-year average P/B ratio of -14.11, the current P/B ratio is about -103.77% higher. PAVmed Inc (PAVM) has a Forward Free Cash Flow (FCF) yield of approximately -213.67%. Compared to its 3-year average FCF yield of -272.29%, the current FCF yield is approximately -21.53% lower. Relative to its 5-year average FCF yield of -170.20% , the current FCF yield is about 25.54% lower.
0.53
P/B
Median3y
0.62
Median5y
-14.11
-215.07
FCF Yield
Median3y
-272.29
Median5y
-170.20

Competitors Valuation Multiple

The average P/S ratio for PAVM's competitors is 7.45, providing a benchmark for relative valuation. PAVmed Inc Corp (PAVM) exhibits a P/S ratio of 42.27, which is 467.31% above the industry average. Given its robust revenue growth of -99.21%, this premium appears unsustainable.

Performance Decomposition

1Y
3Y
5Y
Market capitalization of PAVM decreased by 34.00% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 0.00 to 0.61.
The secondary factor is the Revenue Growth, contributed -99.21%to the performance.
Overall, the performance of PAVM in the past 1 year is driven by P/E Change. Which is more unsustainable.
-99.21%
1.01M → 8.00K
Revenue Growth
+
-12800.71%
-1.83K → 232.79K
Margin Expansion
+
12865.92%
0.00 → 0.61
P/E Change
=
-34.00%
0.87 → 0.57
Mkt Cap Growth

FAQ

arrow icon

Is PAVmed Inc (PAVM) currently overvalued or undervalued?

PAVmed Inc (PAVM) is now in the Fair zone, suggesting that its current forward PS ratio of 42.54 is considered Fairly compared with the five-year average of -3.08. The fair price of PAVmed Inc (PAVM) is between to according to relative valuation methord.
arrow icon

What is PAVmed Inc (PAVM) fair value?

arrow icon

How does PAVM's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for PAVmed Inc (PAVM) as of Jul 29 2025?

arrow icon

What is the current FCF Yield for PAVmed Inc (PAVM) as of Jul 29 2025?

arrow icon

What is the current Forward P/E ratio for PAVmed Inc (PAVM) as of Jul 29 2025?

arrow icon

What is the current Forward P/S ratio for PAVmed Inc (PAVM) as of Jul 29 2025?